Literature DB >> 11207113

Plasmodium falciparum: production and characterization of rat monoclonal antibodies specific for the sexual-stage Pfs48/45 antigen.

W Roeffen1, K Teelen, J van As, M vd Vegte-Bolmer, W Eling, R Sauerwein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11207113     DOI： 10.1006/expr.2000.4586

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN： 0014-4894            Impact factor:   2.011


× No keyword cloud information.
  22 in total

1.  Sequence polymorphisms in Pvs48/45 and Pvs47 gametocyte and gamete surface proteins in Plasmodium vivax isolated in Korea.

Authors:  Mi Kyung Woo; Kyeong Ah Kim; JuYeon Kim; Jun Seo Oh; Eun Taek Han; Seong Soo A An; Chae Seung Lim
Journal:  Mem Inst Oswaldo Cruz       Date:  2013-05       Impact factor: 2.743

Review 2.  Malaria vaccines since 2000: progress, priorities, products.

Authors:  Patrick E Duffy; J Patrick Gorres
Journal:  NPJ Vaccines       Date:  2020-06-09       Impact factor: 7.344

3.  Naturally acquired immune responses to Plasmodium falciparum sexual stage antigens Pfs48/45 and Pfs230 in an area of seasonal transmission.

Authors:  André Lin Ouédraogo; Will Roeffen; Adrian J F Luty; Sake J de Vlas; Issa Nebie; Edith Ilboudo-Sanogo; Nadine Cuzin-Ouattara; Karina Teleen; Alfred B Tiono; Sodiomon Bienvenu Sirima; Jan-Peter Verhave; Teun Bousema; Robert Sauerwein
Journal:  Infect Immun       Date:  2011-10-03       Impact factor: 3.441

4.  Correctly folded Pfs48/45 protein of Plasmodium falciparum elicits malaria transmission-blocking immunity in mice.

Authors:  Nikolay S Outchkourov; Will Roeffen; Anita Kaan; Josephine Jansen; Adrian Luty; Danielle Schuiffel; Geert Jan van Gemert; Marga van de Vegte-Bolmer; Robert W Sauerwein; Hendrik G Stunnenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-10       Impact factor: 11.205

5.  Development of a single-replicon miniBYV vector for co-expression of heterologous proteins.

Authors:  Alex Prokhnevsky; Tarlan Mamedov; Brett Leffet; Rahila Rahimova; Ananya Ghosh; Vadim Mett; Vidadi Yusibov
Journal:  Mol Biotechnol       Date:  2015-02       Impact factor: 2.695

Review 6.  Antibodies against Plasmodium falciparum malaria at the molecular level.

Authors:  Jean-Philippe Julien; Hedda Wardemann
Journal:  Nat Rev Immunol       Date:  2019-08-28       Impact factor: 53.106

7.  Comparison of Intranasal Outer Membrane Vesicles with Cholera Toxin and Injected MF59C.1 as Adjuvants for Malaria Transmission Blocking Antigens AnAPN1 and Pfs48/45.

Authors:  Michael Pritsch; Najib Ben-Khaled; Michael Chaloupka; Sebastian Kobold; Nicole Berens-Riha; Annabell Peter; Gabriele Liegl; Sören Schubert; Michael Hoelscher; Thomas Löscher; Andreas Wieser
Journal:  J Immunol Res       Date:  2016-04-27       Impact factor: 4.818

8.  Transmission-blocking activity of antibodies to Plasmodium falciparum GLURP.10C chimeric protein formulated in different adjuvants.

Authors:  Will Roeffen; Michael Theisen; Marga van de Vegte-Bolmer; GeertJan van Gemert; Theo Arens; Gorm Andersen; Michael Christiansen; Laxman Sevargave; Shrawan Kumar Singh; Swarnendu Kaviraj; Robert Sauerwein
Journal:  Malar J       Date:  2015-11-09       Impact factor: 2.979

9.  Effects of transmission-blocking vaccines simultaneously targeting pre- and post-fertilization antigens in the rodent malaria parasite Plasmodium yoelii.

Authors:  Li Zheng; Wei Pang; Zanmei Qi; Enjie Luo; Liwang Cui; Yaming Cao
Journal:  Parasit Vectors       Date:  2016-08-08       Impact factor: 3.876

10.  An inter-laboratory comparison of standard membrane-feeding assays for evaluation of malaria transmission-blocking vaccines.

Authors:  Kazutoyo Miura; Will J R Stone; Karin M Koolen; Bingbing Deng; Luwen Zhou; Geert-Jan van Gemert; Emily Locke; Merribeth Morin; Teun Bousema; Robert W Sauerwein; Carole A Long; Koen J Dechering
Journal:  Malar J       Date:  2016-09-09       Impact factor: 2.979
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.